Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital()

BACKGROUND: Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines have been approved recently, and public concern regarding the risk of anaphylactic reactions arose after a few cases during the first days of mass vaccination. Polyethylene glycol (PEG) has been suggested as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Paoletti, Giovanni, Racca, Francesca, Piona, Alessandra, Melone, Giulio, Merigo, Morena, Puggioni, Francesca, Ferri, Sebastian, Azzolini, Elena, Lagioia, Michele, Lamacchia, Donatella, Cataldo, Giuseppe, Cecconi, Maurizio, Canonica, Giorgio Walter, Heffler, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8030995/
https://www.ncbi.nlm.nih.gov/pubmed/33850601
http://dx.doi.org/10.1016/j.waojou.2021.100541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8030995/
https://www.ncbi.nlm.nih.gov/pubmed/33850601
http://dx.doi.org/10.1016/j.waojou.2021.100541

Ejemplares similares